Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic and orthopedic markets. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with companies executive. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to one of our industry newsletters.
Recently Added
Ophthalmic Laser Market Expected to Total $406 Million in 2019
.jpg)
Global revenue for ophthalmic lasers—photocoagulation, photodisruption (YAG), and SLT—along with maintenance, accessories, and endoprobes, will total nearly $406 million in 2019 and grow at a compo...
Positive US Payer Decisions Expected to Drive Artificial Disc Replacement Market
Currently, 11 artificial disc replacement (ADR) devices are approved by the FDA. The first ADRs were for lumbar cases. However, insurance companies in the US stopped covering the procedure in 2013 ...
2019 AAO: Delivery Techniques for Gene, Cell Therapy Take Center Stage at Retina Subspecialty Day
The American Academy of Ophthalmology’s Retina Subspecialty Day cast a big net with its 2019 agenda, covering surgical and medical retina and diagnostics. The two-day program preceded the AAO’s ann...
2019 AAO: Cornea Sessions Focus on Keratoconus, Ectasia
Keratoconus and ectasia were frequent topics in conference sessions and during the Refractive and Cornea Subspecialty Days at the 2019 AAO meeting. Physicians were eager to gain a better understand...
Ophthalmic Deals Surge in 2018-2019; Most Transactions Involve New Ventures
Ophthalmic deals garnered over $9 billion from January 2018 through October 2019, driven largely by dry eye and retina related fundraising. Over 100 transactions occurred during this period, and ov...
Aurinia Applies Pressure in Race for Next Dry Eye Pharmaceutical Drug
Aurinia Pharmaceuticals’ initiation of its Phase II/III AUDREY trial in dry eye keeps Aurinia in the middle of the pack of companies racing to develop the next pharmaceutical treatment for dry eye ...
Regenxbio Sues FDA over Unexplained Clinical Holds Placed on Trials
Gene therapy company Regenxbio has filed a lawsuit against the US FDA and Health Secretary Alex Azar II over FDA regulators placing clinical holds on two of the company’s clinical trials for RGX-31...
Bausch Health Licenses Clearside’s Xipere for Macular Edema with Uveitis
Bausch Health and Clearside Biomedical have agreed on a deal to develop and commercialize Clearside’s Xipere (triamcinolone acetonide suprachoroidal injectable suspension) in the US and Canada, the...
2019 AAO: Sessions Showcase New and Next-Generation IOLs
Alcon’s PanOptix trifocal lens garnered much of the attention at refractive- and cataract-focused sessions and on the exhibit floor at the 2019 meeting of the American Academy of Ophthalmology, hel...
2019 AAO: Doctors, Private Equity Firms Discuss Range of Factors Involved in Consolidation
Private equity was a common theme at the 2019 AAO meeting, and discussions often centered on the increasing consolidation within ophthalmology. Sessions focused on educating ophthalmologists and pr...
2019 AAO: Floaters Symposium Evaluates the Latest Developments in Treatment
Ellex and the International Ophthalmic Floater Society (IOFS) sponsored a symposium on advancements in technology that have improved the opportunities for floater treatment. The event was held in c...
2019 AAO: Surgeons Debate Value of 3D Displays at Retina Subspecialty Day
A debate on 3D heads-up displays stood out during the Retina Subspecialty Day because the discussion differed greatly from the terms used to market the devices just three years ago. Jennifer Lim, M...
Past News Stories
OIS Draws More Than 1,150 for Summit Ahead of AAO Meeting
A record crowd attended the 2019 Ophthalmology Innovation Summit in advance of the AAO meeting. The meeting was held Oct. 10 at the Hilton San Francisco Union Square. Forty-one percent of the 1,150...
Amarantus Licenses MANF Retinal Candidate, Other Assets to Emerald Organic Growth
Amarantus Bioscience announced Oct. 24 that it agreed to license its therapeutic assets to Emerald Organic Growth, a cannabinoid-based health sciences company located in Holbrook, New York. It is u...
Oyster Point Pharma Leads Latest Fundraising Efforts with $92 Million IPO
Oyster Point Pharma led recent fundraising efforts by ophthalmic companies, raising $92 million in gross proceeds in its initial public offering. Other firms with financing deals included Nicox, ra...
J&J Vision Shuts Down Sightbox Contact Lens Service Acquired in 2017
Johnson & Johnson Vision (J&J Vision) announced Oct. 28 that it will cease customer-facing operations for Sightbox, its online contact lens subscription service, while it evaluates options for the ...
Ophthalmic Laser Market Expected to Total $406 Million in 2019
Global revenue for ophthalmic lasers—photocoagulation, photodisruption (YAG), and SLT—along with maintenance, accessories, and endoprobes, will total nearly $406 million in 2019 and grow at a compo...
Spencer Thornton, MD, Dies at Age 90
Spencer P. Thornton, MD, FACS, a renowned ophthalmologist and former president of the American Society of Cataract and Refractive Surgery (ASCRS), died Oct. 26 at the age of 90. Colleagues remember...
Market Scope Weekly Ophthalmic Surgeon Poll for November 2019
November 2019 Ophthalmic News Briefs
.jpg)
Coherus BioSciences will market and distribute Bioeq AG’s ranibizumab biosimilar candidate in the US under a licensing agreement announced Nov. 6. Bioeq, of Switzerland, will retain responsibility ...
Medacta and Geisinger Extend Lifetime Guarantee to Knee Revisions
Medacta and Geisinger announced in 2018 that they were launching a pilot program for lifetime-guaranteed hip replacements; the companies added knee replacements to the program in March 2019. On Nov...
Bioness PNS Achieves Positive Results for Focal Mononeuropathy Treatment
Bioness, a California-based provider of the StimRouter Peripheral Nerve System (PNS), announced Nov. 14 that positive clinical trial results for the device were published in the November issue of P...
CMS Increases SI Joint Arthrodesis Physician Payment by 27 Percent
Announced Nov. 5, the US Centers for Medicare and Medicaid Services increased Medicare physician payment for sacroiliac (SI) joint arthrodesis. Starting Jan. 1, the relative value units for the pro...
Spineology Fusion Trial Achieves Positive 24-Month Results
Spineology announced Nov. 4 that 24-month outcomes for its SCOUT clinical trial are positive. The trial is prospective, multi-center, and non-randomized, and it follows IDE protocol. One hundred an...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.